Comparison of clinical outcomes in women with advanced ovarian cancer undergoing neoadjuvant chemotherapy who receive threevs greater than three cycles of chemotherapy after interval cytoreductive surgery

Authors :: Jean A. Hurteau
E.D. Moore
Josephine S. Kim
C. Wang
Tilley Jenkins Vogel
Carolyn V. Kirschner
Gustavo C. Rodriguez
E.N. Prendergast
Joshua G. Cohen
Rebecca A. Brooks
Source :: Gynecologic Oncology. 145:71-72
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: medicine.medical_specialty
Advanced ovarian cancer
Chemotherapy
Oncology
business.industry
General surgery
medicine.medical_treatment
medicine
Obstetrics and Gynecology
Interval (graph theory)
business
Cytoreductive surgery

Full Text Access

Tools